NeoDose Pro — Neonatal Clinical Calculator OFFLINE · Complete Database

Complete neonatal pharmacology database: drug dosing (weight/GA/PNA based), emergency protocols, drug interactions & IV compatibility, TDM targets, advanced pharmacotherapy, and calculation tools. Enter patient parameters and every drug calculates instantly.

— entries — categories PMA/PNA interval logic Emergency protocols Interaction matrices
⚠ EDUCATIONAL REFERENCE ONLY — Verify every dose against NeoFax®, Lexicomp®, manufacturer labeling and your institutional protocol BEFORE administration. Independent double-check required.
Postmenstrual Age (auto)—

🚨 NICU & Emergency Protocols

Step-by-step management of the most critical neonatal emergencies.

❤️ Neonatal Resuscitation (NRP) — Medications CRITICAL

1Initial steps: Warm, dry, stimulate, position airway. Begin PPV if apneic or HR <100.
2PPV: Rate 40–60/min. O2 start 21% (term) / 21–30% (preterm), titrate to SpO2 targets (60–65% @1min → 85–95% @10min).
3Chest compressions: Start if HR <60 despite 30s effective PPV. Two-thumb technique, 3:1 ratio (90 compressions : 30 breaths). Raise O2 to 100%.
4Epinephrine (if HR <60 despite PPV + compressions): IV/IO 0.01–0.03 mg/kg (0.1–0.3 mL/kg of 1:10,000) + NS flush. ET route 0.1 mg/kg only while obtaining IV. Repeat q3–5 min.
5Volume expander (suspected hypovolemia): NS or O-negative blood 10–20 mL/kg IV over 5–10 min.
Sodium bicarbonate, naloxone, and atropine are NOT part of initial NRP resuscitation. Always ensure effective ventilation FIRST.

⚡ Hyperkalemia (K⁺ ≥6.5 mEq/L or ECG changes) CRITICAL

1Stop all K⁺ sources (fluids, feeds, K-containing additives) immediately.
2Myocardial stabilization: Calcium gluconate 10% 0.5–1 mL/kg IV slowly over 5–10 min with continuous ECG (onset minutes, lasts 30–60 min).
3Intracellular shift: Regular insulin 0.05–0.1 units/kg IV + Dextrose 0.5 g/kg (5 mL/kg D10W). Check glucose q30min ×2h. Add NaHCO₃ 1–2 mEq/kg if acidotic.
4Elimination: Loop diuretics (if renal function intact), exchange transfusion, or dialysis/CVVH for refractory cases.
⛔ NEVER use sodium polystyrene sulfonate (Kayexalate) in neonates — fatal intestinal necrosis risk.

🧠 Neonatal Seizure Algorithm CRITICAL

1First-line: Phenobarbital 20 mg/kg IV load (up to 40 mg/kg for refractory). Give slowly over 30–60 min.
2Second-line: Fosphenytoin 20 mg PE/kg IV (with ECG/BP monitoring) OR Levetiracetam 40–60 mg/kg IV load.
3Refractory: Midazolam infusion, lidocaine, or propofol under continuous aEEG/EEG monitoring.
80% of neonatal seizures are subclinical — use EEG/aEEG to confirm. Consider stopping AEDs if seizure-free 2–3 days (with neurology consult).

🩸 Neonatal Hypoglycemia COMMON

1Symptomatic: D10W 2 mL/kg (= 200 mg/kg glucose) IV over 5–10 min.
2Then: Start/adjust infusion at GIR 6–8 mg/kg/min. Recheck glucose 15–30 min after bolus.
3If requirement > GIR 12–15: Evaluate for hyperinsulinism (insulin level during hypoglycemia), consider glucagon, diazoxide, endocrine consult.
Avoid D25/D50 boluses in neonates (rebound hypoglycemia, hyperosmolar injury).

💊 Neonatal Opioid Withdrawal (NOWS/NAS) COMMON

1Assess: Modified Finnegan scoring. Start pharmacotherapy if scores consistently ≥8.
2Treat: Oral morphine 0.1 mg/kg/dose q3–4h. Titrate ±10–20% based on scores.
3Wean: Decrease dose by 10% every 48–72h once stable.
⛔ NEVER give naloxone to an infant of an opioid-dependent mother — precipitates acute withdrawal and intractable seizures. Non-pharmacologic care (rooming-in, swaddling, frequent feeds) is first-line.

🫁 PPHN (Persistent Pulmonary Hypertension) CRITICAL

1Optimize ventilation: Avoid hyper/hypocarbia, maintain normothermia, adequate oxygenation.
2Inhaled Nitric Oxide: Start 20 ppm, wean to 5 ppm before discontinuation. Contraindicated in left-sided obstructive lesions.
3Sildenafil (rescue): 0.4–1 mg/kg/dose q6h PO/IV. Milrinone for LV dysfunction. Confirm with echocardiography.

⚠ Drug Interactions & IV Compatibility

Critical interactions and compatibility matrices for the NICU.

🚫 Critical Drug-Drug Interactions

Drug 1Drug 2Consequence
CeftriaxoneCalcium-containing fluidsFATAL precipitate in lungs/kidneys — ABSOLUTE contraindication
Na BicarbonateCalcium gluconateImmediate precipitation — separate lines, flush with NS
PhenobarbitalLamotrigineCYP induction → ↓ lamotrigine levels
Valproic acidLamotrigineLevels ↑ >200% — reduce lamotrigine 50%
DomperidoneFluconazoleQT prolongation / arrhythmia
AdenosineDipyridamolePotentiated effect — reduce dose

💉 Y-Site Compatibility Highlights

DrugCompatibleIncompatible
LevetiracetamCisatracurium, dexmedetomidine, fosphenytoin, vancomycin, norepinephrinePiperacillin-tazobactam (micro-precipitate)
KetamineFentanyl, hydromorphone, midazolam, morphineAcyclovir, ampicillin, furosemide
AmiodaroneFurosemide (specific conc.)PN solutions — use dedicated line

🥣 Parenteral Nutrition (PN) Compatibility

  • NEVER add medications to a PN bag without explicit, formulation-specific compatibility data.
  • Incompatible with PN: Amiodarone, pentobarbital, phenobarbital, acyclovir, rifampin.
  • Ambiguous: Ampicillin, fosphenytoin, ceftazidime (depends on lipid emulsion & Ca/Phos).
  • Always use a dedicated lumen for high-risk drugs.

🚫 Drugs to AVOID in Neonates

  • Sodium polystyrene sulfonate — intestinal necrosis
  • Chloramphenicol — gray baby syndrome
  • Sulfonamides / TMP-SMX — kernicterus (<6 weeks)
  • Ceftriaxone in jaundiced neonates — kernicterus + Ca precipitate
  • Aspirin/salicylates — Reye syndrome
  • Codeine, tramadol, meperidine — toxic metabolites
  • Propofol prolonged infusion — PRIS
  • Benzyl alcohol diluents — gasping syndrome
  • Tetracyclines/fluoroquinolones — avoid unless benefit > risk
  • Naloxone in opioid-dependent mothers' infants

🧴 Dermatology Safety (Preterm Skin)

  • AVOID olive oil — oleic acid disrupts stratum corneum, ↑ TEWL.
  • Use fractionated coconut oil or sunflower oil for emollients.
  • For <30 weeks GA: use aqueous CHG 0.2–0.5%, avoid alcohol-based prep (chemical burns).
  • Avoid povidone-iodine — transient hypothyroidism.
  • Use silicone-based adhesive removers; apply non-alcoholic barrier film before tapes.
  • Diaper dermatitis: Zinc oxide 40% BID; add antifungal if Candida.

⏱ Infusion Rate & Dilution Safety

  • If calculated volume <0.1 mL → always dilute.
  • Use standardized unit-approved concentrations only.
  • For ELBW (<500g): use extra-dilute concentrations so volume >0.1 mL and rate >0.1 mL/h.
  • Double-check all high-alert infusions independently.

🎯 Therapeutic Drug Monitoring & Safety Rules

TDM targets, organ-impairment adjustments, and the 10 golden rules.

📊 TDM Targets

DrugTargetTiming
GentamicinPeak 5–10 · Trough <1–2 mcg/mLPeak 30 min post-infusion; trough pre-dose
VancomycinTrough 10–15 (15–20 severe/MRSA)Before 3rd–4th dose
PhenytoinFree 1–2 mcg/mL (total unreliable)Steady state, free level
Caffeine5–25 mcg/mLOnly if toxicity/lack of efficacy
Theophylline6–11 mcg/mL (apnea)Steady state
Phenobarbital15–40 mcg/mLSteady state

🫘 Renal Impairment Adjustments

  • Interval extension — preferred for concentration-dependent drugs (aminoglycosides).
  • Dose reduction — for time-dependent drugs (beta-lactams), keep time > MIC.
  • Hold K⁺/Na⁺ additives until urine output confirmed.
  • Renal maturation follows PMA, not just PNA.
  • GFR ~14 mL/min at 32w, doubles in 2 weeks, adult levels by 2 years.

🫁 Hepatic Impairment Adjustments

  • Phenytoin: measure FREE level (protein binding drops further).
  • Midazolam: reduce dose, watch propylene glycol toxicity.
  • Lacosamide: contraindicated in Child-Pugh C.
  • UGT/glucuronidation immature at birth — morphine, paracetamol accumulate.

✅ The 10 Golden Rules of Safety

  • 1. Dose on actual measured weight in kg.
  • 2. Independent double-check for high-alert drugs.
  • 3. Volume <0.1 mL → dilute first.
  • 4. Use standardized concentrations only.
  • 5. Verify PMA/PNA intervals vs NeoFax/Lexicomp.
  • 6. Check Y-site & PN compatibility.
  • 7. Avoid benzyl alcohol diluents in preterms.
  • 8. Adjust for renal/hepatic impairment + TDM.
  • 9. Document indication, dose, route, time, monitoring.
  • 10. When in doubt — call the pharmacist.

🧬 Pharmacokinetic Principles (ADME)

  • Absorption: Alkaline gastric pH at birth; thin preterm skin ↑ transdermal absorption.
  • Distribution: TBW 87% (preterm) → ↑ Vd for hydrophilic drugs (need higher mg/kg loads). Low protein binding → ↑ free fraction.
  • Metabolism: CYP3A7 dominant at birth; UGT2B7 (morphine) only 10–20% adult activity.
  • Elimination: Nephrogenesis complete at 34–36w; GFR matures by 2 years.

⚖ High-Alert Medications

  • Insulin, Heparin, Opioids (morphine, fentanyl)
  • Inotropes (dopamine, epinephrine, norepinephrine)
  • Concentrated electrolytes (KCl, NaCl 3%, Ca gluconate)
  • Chemotherapy, Digoxin, Aminophylline
  • All require independent double-check + smart pump libraries.

🧮 Calculation Tools

GIR, fluid rates, infusion conversion, dilutions, exchange transfusion, mg→mL.

Glucose Infusion Rate (GIR)

GIR = Dextrose % × Rate (mL/h) ÷ (6 × Weight). Typical: 4–8 mg/kg/min.

GIR: —
Rate: —

Maintenance IV Fluid Rate

Converts mL/kg/day into pump mL/h.

—
Day-1: term 60–80, preterm 80–100 mL/kg/day. Advance 10–20 mL/kg/day.

General Infusion Rate Calculator

Dose ⇄ pump rate conversion.

—
—

Dilution (C1×V1 = C2×V2)

Leave ONE field blank to solve.

—

Exchange Transfusion Volumes

Double-volume ≈ 2 × blood volume (80 mL/kg term, 90–95 preterm).

—

mg ⇄ mL Quick Converter

Volume = Dose ÷ Concentration.

—
If volume <0.1 mL, dilute the product first.

📚 Reference & Education

Fluid schedules, electrolyte needs, pharmacology fundamentals.

Maintenance IV Fluids (mL/kg/day)

InfantDay 1Day 2–3Week 1 end
Term60–8080–100120–150
Late preterm70–9090–120140–160
Preterm/ELBW80–100100–130140–180
  • Start dextrose 7.5–10% (GIR 4–8); target glucose 70–150.
  • Target weight loss ≤8–10% (term), ≤10–15% (ELBW).

Electrolyte & Mineral Requirements

ComponentDose
Sodium2–4 mEq/kg/day (preterm 3–6)
Potassium1–3 mEq/kg/day (only with urine output)
Calcium60–80 mg/kg/day elemental (preterm 90–120)
Phosphorus45–90 mg/kg/day (preterm)
Magnesium0.15–0.3 mEq/kg/day
ProteinTerm 2–3 g/kg/day; ELBW 3.5–4 g/kg/day

Why Intervals Depend on PMA/PNA

  • PMA = GA + postnatal age. Renal/hepatic maturation follows PMA.
  • Renally-cleared drugs (ampicillin, gentamicin, vancomycin, cefotaxime) use GA/PMA + PNA tables for the interval; the mg/kg per dose stays constant.
  • Extremely preterm (PMA <29w) clear aminoglycosides slowly → q36–48h with level monitoring.
  • After PNA ~7–14 days, intervals shorten by one step.

Dosing Formulas

  • Per-dose: Dose = (mg/kg/dose) × weight; Volume = Dose ÷ conc.
  • Daily: Total = (mg/kg/day) × weight; per-dose = total ÷ doses/day.
  • Infusion: mL/h = dose × weight × 60 ÷ conc (mcg/kg/min).
  • GIR: Dextrose% × rate ÷ (6 × weight).
  • Volume <0.1 mL → dilute so dose is measurable.

Sources Summarized

  • NeoFax® / Micromedex Neonatal Formulary
  • Harriet Lane Handbook — Neonatal section
  • AAP Red Book®; AAP Vitamin K & Hep B policies
  • NRP Textbook (8th ed.) — resuscitation meds
  • Manufacturer labeling (surfactants, ibuprofen lysine, caffeine citrate, valganciclovir CASG)
  • DART protocol (dexamethasone BPD); Watterberg hydrocortisone BPD-prevention
  • ILCOR / AHA neonatal resuscitation guidelines
Dosing evolves. Where sources differ, this tool displays the most widely used schema with a range — always confirm with your current reference and institutional protocol.